InsidersTradesSigma
Total declarations
Company
▲ Purchases (23 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
23
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+20.2%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Krogulski Kenneth, Director. Insider active across 1 company, notably Cumberland Pharmaceuticals INC. In total, 47 reports have been logged. Split: 23 buys · 0 sell. Total volume traded: €6k. Activity tracked since 17 March 2021. The latest transaction was disclosed on 18 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Krogulski Kenneth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
1,800 shares@ US$2.808.4% of flowCommon StockSEC:0001087294-26-000037:0
124 shares@ US$2.360.5% of flowCommon StockSEC:0001087294-26-000002:0
68 shares@ US$2.800.3% of flowCommon StockSEC:0001087294-25-000025:0
68 shares@ US$3.310.4% of flowCommon StockSEC:0001695580-25-000004:0
62 shares@ US$3.540.4% of flowCommon StockSEC:0001087294-25-000006:0
68 shares@ US$3.440.4% of flowCommon StockSEC:0001628280-25-041983:0
Canonical exit: 30 Oct 2025 (T+90)
80 shares@ US$3.560.5% of flowCommon StockSEC:0001628280-25-039397:0
Canonical exit: 29 Sept 2025 (T+90)
45 shares@ US$5.200.4% of flowCommon StockSEC:0001628280-25-034814:0
Canonical exit: 31 Aug 2025 (T+90)
45 shares@ US$4.860.4% of flowCommon StockSEC:0001628280-25-029856:0
Canonical exit: 30 Jul 2025 (T+90)
45 shares@ US$4.240.3% of flowCommon StockSEC:0001628280-25-024346:0
Canonical exit: 30 Jun 2025 (T+90)
47 shares@ US$5.540.5% of flowCommon StockSEC:0001628280-25-016741:0
Canonical exit: 1 Jun 2025 (T+90)
1,000 shares@ US$5.179.2% of flowCommon StockSEC:0001628280-25-013546:0
6,500 shares@ US$1.7120.0% of flowCommon StockSEC:0001628280-25-003183:0
415 shares@ US$1.331.0% of flowCommon StockSEC:0001628280-24-052603:0
Canonical exit: 2 Mar 2025 (T+90)
380 shares@ US$1.150.8% of flowCommon StockSEC:0001628280-24-050104:0
Canonical exit: 30 Jan 2025 (T+90)
309 shares@ US$1.270.7% of flowCommon StockSEC:0001628280-24-045328:0
Canonical exit: 30 Dec 2024 (T+90)
250 shares@ US$1.380.6% of flowCommon StockSEC:0001628280-24-042110:0
221 shares@ US$1.470.6% of flowCommon StockSEC:0001214659-24-016036:0
221 shares@ US$1.470.6% of flowCommon StockSEC:0001214659-24-013691:0
134 shares@ US$1.520.4% of flowCommon StockSEC:0001214659-24-011871:0
5,000 shares@ US$1.7115.4% of flowCommon StockSEC:0001214659-24-005226:0
379 shares@ US$1.691.1% of flowCommon StockSEC:0001214659-23-017030:0
66 shares@ US$1.730.2% of flowCommon StockSEC:0001214659-23-016097:0
280 shares@ US$1.851.0% of flowCommon StockSEC:0001214659-23-015351:0
280 shares@ US$2.241.2% of flowCommon StockSEC:0001214659-23-014538:0
25 of 47 declarations
About Krogulski Kenneth
Krogulski Kenneth is Administrateur at Cumberland Pharmaceuticals INC (XNAS). He has 47 filings in total, and across the 47 sampled filings, buys amount to EUR 5889 and sells to EUR 0, with filings ranging from 2021-06-11 to 2026-03-20. The most frequent transaction nature is Acquisition.
